Drug Trial Radar · NCT02560584
A Study of Blue Light Flexible Cystoscopy With Cysview in the Detection of Bladder Cancer in the Surveillance Setting
Last checked: Nov 20, 2026Latest source record: Jul 2, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
304
Actual
Start
Oct 1, 2015
Primary completion
Apr 5, 2017
Study completion Apr 5, 2017
Sponsor
- Lead sponsor
- PhotocureIndustry
- Sponsor type
- Industry
- Collaborators
- KARL STORZ Endoscopy-America, Inc.
- First posted
- Sep 25, 2015
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Diagnostic
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to investigate if blue light cystoscopy with Cysview improves detection of tumors in patients with bladder cancer during surveillance cystoscopy, using the KARL STORZ D-Light C PDD Flexible Videoscope System. Another purpose is to investigate if Cysview and blue light is safe and effective when used repeatedly.
Conditions
- Bladder Cancer
Interventions
Hexaminolevulinate hydrochlorideDrug
Instillation in bladder
KARL STORZ D-Light C PDD Flexible Videoscope SystemDevice
Cystoscopy procedure
Primary outcomes
What the sponsor says the trial is designed to measure.
- Proportion of Patients With Histologically Confirmed Malignancy Where Malignancy is Only Detected With Blue Light Cystoscopy With Cysview and Not White Light CystoscopyTime frame: At time of cystoscopy procedure
Locations
17 sites in 1 country. Site status is shown where the registry gives one.
USC Norris Comprehensive Cancer Center
Los Angeles, California
University of Chicago Medical Center
Chicago, Illinois
University of Iowa
Iowa City, Iowa
Johns Hopkins University
Baltimore, Maryland
University of Minnesota
Minneapolis, Minnesota
NYU Langone Urology Associates
New York, New York
Columbia University Medical Center
New York, New York
Montefiore Medical Center
The Bronx, New York
University of North Carolina, Department of Urology
Chapel Hill, North Carolina
Ohio State University The James Cancer Hospital
Columbus, Ohio
University of Oklahoma-Stephenson Cancer Center
Oklahoma City, Oklahoma
Thomas Jefferson University
Philadelphia, Pennsylvania
Vanderbilt University Medical Center
Nashville, Tennessee
UT Southwestern Medical Center
Dallas, Texas
MD Anderson Cancer Center
Houston, Texas
Michael E. DeBakey VA Medical Center
Houston, Texas
University of Wisconsin
Madison, Wisconsin
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.